Hydralazine Hydrochloride
NDC 82868-045, Hydralazine Hydrochloride, tablet, from Northwind Health Company, LLC.
- Product NDC
- 82868-045
- Status
- Listed
- Labeler
- Northwind Health Company, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA040858
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82868-045 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HYDRALAZINE HYDROCHLORIDE25 mg/1
Pharmacologic classes
Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82868-045-30 | 82868004530 | 30 TABLET in 1 BOTTLE, PLASTIC (82868-045-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1275dd50-d97f-2e8f-e063-6394a90a4a67
Use it
Look up 82868-045 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82868-045 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82868-045. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.